Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918083 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
A strong survival impact of the ratio of PD-1+/CD8+ TILs was observed in EHBD cancer. In the poor prognostic subgroup, the blockade of the immune checkpoint in combination with conventional multimodality treatment needs to be considered.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yu Jin Lim, Jaemoon Koh, Kyubo Kim, Eui Kyu Chie, BoKyong Kim, Kyoung Bun Lee, Jin-Young Jang, Sun-Whe Kim, Do-Youn Oh, Yung-Jue Bang, Sung W. Ha,